NAPIGEN, Inc.’s Gene-Edited Rice With CMS is Not Subject to Regulation According to USDA
|

NAPIGEN, Inc.’s Gene-Edited Rice With CMS is Not Subject to Regulation According to USDA

The cytoplasmic male sterility (CMS) trait is a vital component of developing high-yielding hybrid rice. The USDA has stated that NAPIGEN, Inc.’s rice with gene-edited CMS is not subject to regulation, allowing the company to take its first step towards commercializing the rice plants.